 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Current Price	$0.0001
Prev Close	$0.000001
Open	$0.0001
Dividend Yield	N/A
50-Day Moving Average	$0.00
Beta	-5.23
Avg. Volume	318.64
PE Ratio	N/A

52-Week High	$0.0001
52-Week Low	$0.00
Market Capitalization	$3,100.00
EPS	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

SNNA Sienna Biopharmaceuticals

About

Feed

Fundamentals

News